We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
M cell Targeting by a Claudin 4 Targeting Peptide Can Enhance Mucosal IgA Responses
News

M cell Targeting by a Claudin 4 Targeting Peptide Can Enhance Mucosal IgA Responses

M cell Targeting by a Claudin 4 Targeting Peptide Can Enhance Mucosal IgA Responses
News

M cell Targeting by a Claudin 4 Targeting Peptide Can Enhance Mucosal IgA Responses

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "M cell Targeting by a Claudin 4 Targeting Peptide Can Enhance Mucosal IgA Responses"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Background
Mucosal immune surveillance is thought to be largely achieved through uptake by specialized epithelial M cells. We recently identified Claudin 4 as an M cell target receptor and developed a Claudin 4 targeting peptide (CPE) that can mediate uptake of nanoparticles through Nasal Associated Lymphoid Tissue (NALT) M cells.

Results
To test its utility in vaccine delivery and probe the role of M cells in mucosal immunity, we immunized mice intranasally using a recombinant Influenza hemagglutinin (HA) fused to the CPE peptide. We found that the recombinant HA was immunogenic on intranasal administration, and inclusion of the CPE targeting peptide induced higher mucosal IgA responses. This mucosal administration also induced systemic serum IgG responses with Th2 skewing, but targeting did not enhance IgG responses, suggesting that the IgG response to mucosal immunization is independent of the effects of CPE M cell targeting.

Conclusions
M cell targeting mediated by a Claudin 4-specific targeting peptide can enhance mucosal IgA responses above the response to non-targeted mucosal antigen. Since Claudin 4 has also been found to be regulated in human Peyer's patch M cells, the CPE targeting peptide could be a reasonable platform delivery technology for mucosal vaccination.

This article is published online in BMC Biotechnology and is free to access.

Advertisement